Fluorouracil, Phenylbutyrate, Indomethacin, and Interferon Gamma in Treating Patients With Advanced Colorectal Cancer - Related Studies

Fluorouracil, Phenylbutyrate, Indomethacin, and Interferon Gamma in Treating Patients With Advanced Colorectal Cancer

This study has been completed.

Study NCT00002796. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Colorectal Cancer

2	Additional conditions recognized in this trial
		Colorectal Neoplasms

3	More general conditions related to this trial
		Colonic Diseases
		Digestive System Diseases
		Digestive System Neoplasms
		Gastrointestinal Diseases
		Gastrointestinal Neoplasms
		Intestinal Diseases
		Intestinal Neoplasms
		Neoplasms
		Neoplasms by Site
		Rectal Diseases

4	Interventions listed in this trial
		fluorouracil
		indomethacin
		recombinant interferon gamma
		sodium phenylbutyrate

5	Additional drug interventions recognized in this trial
		4-phenylbutyric acid
		Interferon Type II
		Interferon-gamma, Recombinant
		Interferons

6	More general drug interventions related to this trial
		Analgesics
		Analgesics, Non-Narcotic
		Anti-Infective Agents
		Anti-Inflammatory Agents
		Anti-Inflammatory Agents, Non-Steroidal
		Antimetabolites
		Antimetabolites, Antineoplastic
		Antineoplastic Agents
		Antirheumatic Agents
		Antiviral Agents
		Cardiovascular Agents
		Central Nervous System Agents
		Cyclooxygenase Inhibitors
		Enzyme Inhibitors
		Gout Suppressants
		Immunologic Factors
		Immunosuppressive Agents
		Molecular Mechanisms of Pharmacological Action
		Peripheral Nervous System Agents
		Pharmacologic Actions
		Physiological Effects of Drugs
		Reproductive Control Agents
		Sensory System Agents
		Therapeutic Uses
		Tocolytic Agents

7	Sponsors listed in this trial
		Mount Sinai School of Medicine
		National Cancer Institute (NCI)